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As of April 19, 2021, South Africa has recorded 1.56 million COVID-19 cases and almost 
54,000 deaths1 - more than any other country on the African continent.  The country has 
begun the national rollout of the Johnson & Johnson (J&J) COVID-19 vaccine, with over 
292 thousand doses administered2 it aims to achieve herd immunity by vaccinating at 
least 67 percent of its population (around 40 million people) by the end of 2021.3  The 
government suspended its initial rollout of the AstraZeneca (AZ) vaccine due to concerns 
over its effectiveness, particularly against the new B.1.351 variant, which accounts for 90% 
of the infections in South Africa.4 The J&J vaccine was put on temporary hold in April  due 
to concerns about rare clotting disorders.5 Although data show that expected acceptance 
of COVID-19 vaccines is relatively high, the suspension of two vaccines in South Africa, 
where fear of infection is decreasing, will likely influence public reactions.   
Understanding how individuals and population groups perceive and make sense of 
COVID-19 vaccines is critical to inform the design and implementation of risk 
communication and community engagement (RCCE) strategies, and guide 
interventions aiming to promote and sustain acceptance of COVID-19 vaccines, while 
encouraging compliance with other COVID-19 preventive measures. 
This review syntheses community perceptions of COVID-19 vaccines in South Africa to 
inform RCCE strategies and policies and provides examples of successful practice. It 
draws on multiple secondary data sources: scientific literature, qualitative and 
quantitative studies, grey literature, and mainstream and social media. The review was  
supported by consultation with four local expert key informants from different fields. It is 
part of the Social Science in Humanitarian Action Platform (SSHAP) series on social 
science considerations relating to COVID-19 vaccines. It was written for SSHAP by Tamara 
Roldan de Jong and Anthrologica on request of the UNICEF South Africa Country Office.  
Contributions were made from the RCCE Collective Service East and Southern Africa 
(ESAR) Region. The brief is the responsibility of SSHAP.  
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◼ Vaccine hesitancy in South Africa is often intertwined with distrust in institutions, 
rooted in a history of inequality. An effective pandemic response to COVID-19 requires 
tackling this distrust. Discussions should address misinformation and rumours, but 
also encourage dialogue about social and political issues, embedded in inequalities.  
◼ There is a need for more diverse data from a range of communities. Most of the 
available data is from an adult population, with internet access, living in urban and 
English-speaking settings. Research into other populations focusing on community 
feedback mechanisms can help to understand the complex array of individual, 
sociocultural, and political factors that influence vaccine hesitancy and acceptance.6 
◼ Effective response to vaccine hesitancy will require information about vaccines that is 
accessible, clear and encourages two-way communication.  This includes information 
about vaccine safety, effectiveness, and trial processes. Use context-specific language 
to communicate which specific groups, such as the elderly, prisoners and migrants, 
will be prioritised for vaccination and explain the rationale for these choices.  
◼ It is important to understand and address the specific concerns of various socio-
demographic groups. As far as possible this should be supported by on-the-ground 
research and monitoring of vaccine perceptions to identify each group’s concerns, 
preferred channels and communication needs.  
◼ Understanding and responding people’s needs and priorities can increase the 
acceptance and relevance of COVID-19 vaccines in those contexts. Avoid isolated 
efforts, embed the vaccination strategies into people's priorities, noting they may 
have other livelihood concerns.  
◼ HCWs are an important target audience for RCCE guidance. They are vital as sources 
of trusted information and promoting vaccine acceptance in their communities. They 
need access to information and opportunities to discuss their concerns and questions. 
◼ Tailored strategies may be needed to address the different needs and perceptions 
about and among migrants and refugees. It is important that any such efforts be 
explained as necessary to protect overall public health, to avoid the perception that 
these groups are being singled out for special privileges.  
◼ Enhance community-based responses and community resilience to build trust and a 
sense of social justice. Training and coordination with existing community networks 
and local structures can provide valuable insights. 
◼ One-dimensional and 'easy-to-implement' public health interventions are unlikely to 
be effective. Work with social scientists and community experts in the development 
of material and campaigns to ensure that communities are part of the design and 
development process, and so the response is localised and embedded in the complex 
realities of communities. 
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CONCEPTS OF VACCINE HESITANCY AND CONFIDENCE 
The World Health Organization defines vaccine hesitancy as a ‘delay in acceptance or 
refusal of vaccines despite the availability of vaccination services’.7 It can be seen as a 
continuum ranging from complete acceptance to complete refusal of a specific vaccine 
or of vaccination generally.8–10 Vaccine confidence refers to the belief that vaccination, 
along with the providers, private sector, and political actors behind it, serve the public’s 
best health interests.11 Social science research illustrates that vaccine perceptions are 
shaped by complex socio-political and historical factors.8,12 Vaccine confidence leads in 
turn to vaccine acceptance - the willingness of individuals and communities to be 
vaccinated. These concepts are described fully by other recent SSHAP outputs relating to 
vaccine hesitancy,13 as well as considerations relating to and online information and 
misinformation14 in the context of COVID-19. 
VACCINE ACCEPTANCE AND HESITANCY IN SOUTH 
AFRICA 
Several studies of vaccine perceptions have been undertaken in South Africa since the 
beginning of the COVID-19 outbreak. This evidence consistently shows relatively high 
rates of likely COVID-19 vaccine acceptance. An Africa CDC survey conducted in 
September and October 2020 (n=1,056), found that 76% of South Africans surveyed would 
take the vaccine if it was publicly available and declared safe and effective15 – listing 
amongst the highest rates of the 15 African countries surveyed. A survey on vaccine 
perceptions conducted in January 2021 by the University of Johannesburg and the 
Human Sciences Research Council (UJ-HSRC) (n=10,618), indicated that 67% of 
respondents would take a vaccine, 18% would not take the vaccine, and 15% were unsure 
about taking a COVID.19 vaccine.16 Data from two John Hopkins University (JHU) studies, 
in July and November 2020 (n=4094; 3916), showed likely acceptance at 61% and 60%.17 
Two other surveys, by IPSOS in December/January (n=500+)18 and by the Partnership for 
Evidence-Based Response to COVID-19 (PERC) in February 2021 (n=1,639)19 yielded similar 
results, with 61% of adults in each survey indicating a likelihood to get vaccinated. The 
largest (n=4,900,000) and most recent survey in South Africa tracked by Facebook and 
the University of Maryland in April,20 stated a considerably higher rate of COVID-19 vaccine 
acceptance of almost 70%. A recent rapid assessment survey specifically targeting HCW 
was undertaken by the Department of Health RSA and UNICEF in February (n=22,751), 
also found that 70% would accept the vaccine when it becomes available, while 19% 
remained unsure.21 Those last three surveys, it should be noted, were taken during/after 
the suspension of the AZ and J&J vaccines. 
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There are limited data allowing analysis of vaccine acceptance disaggregated by socio-
demographic characteristics, and what exists is inconsistent across studies or difficult to 
compare due to diverse methodologies. The following highlights the demographic 
trends in acceptance that can be identified based on available data. Additional research 
is needed to fully understand the priorities and perceptions of different demographic 
groups. 
Gender. Africa CDC data show that willingness to accept the COVID-19 vaccine is quite 
consistent across gender (73% of men vs. 78% of women).15 Other surveys, however, 
indicate that men are more likely than women to accept the vaccine. The November 2020 
JHU KAP surveys found that 65% of men and 56% of women would accept a COVID-19 
vaccine.17 The UJ-HSRC study also showed men marginally more inclined than women to 
accept the vaccine (69% vs 65%, respectively).16   
Age. Data indicate that young people may be less likely than older people to accept the 
vaccine. In the UJ-HSRC study, the percentage of those surveyed who would definitely or 
probably get the vaccine was highest amongst those aged over 55 years (74%) and lower 
in younger groups; only 64% of those between 18 and 34 were likely to take the vaccine.16 
The Africa CDC data show a smaller differential, with 73% of those between 18 and 34 
willing to accept a vaccine compared to 78% of those 35 and older.15 This trend is 
consistent with global acceptance rates, where vaccine rejectors skew younger than 
acceptors.22  
Race. Only the UJ-HSRC study provided a racial breakdown of survey responses; 56% of 
white adults were willing to accept a COVID-19 vaccine compared to 69% of Black African 
adults, 68% of Indian adults, and 63% of coloured adults.16  
Income and class status. The scant available data do not indicate a clear and consistent 
association between personal income and vaccine acceptance. Although the UJ-HSRC 
indicates that acceptance varies by income bracket, no pattern is discernible. The same 
is true for self-described class status.16 PERC data show that higher and lower income 
participants (62%) are equally likely to get vaccinated.19 
Education. Only the UJ-HSRC data are broken down by education level. Those data 
suggest that acceptance of a vaccine decreases as education increases, with 72% of those 
with less than matric-level education (grade 12) reporting they will take the vaccine, 
compared to 62% of those who have completed matric and 59% of those with tertiary 
education.16 This contrasts with the Africa CDC report, which notes higher vaccine 
acceptance among graduates.15 
Urban/Rural. Africa CDC data suggests higher COVID-19 vaccine acceptance among 
urban (79%) versus rural (69%) participants. The latter study emphasised that in the more 
heavily urbanised regions of Northern and Eastern Cape, 95% and 98% respectively say 
they would accept the vaccine.15 PERC data found a different pattern, suggesting slightly 
higher (but not significant) levels of acceptance in rural areas when compared to urban 
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(63% vs 59%).19 Additional research to address vaccine perceptions in different 
geographical areas is necessary to allow tailored, localised communication strategies as 
well as to inform programming and rollout logistics. 
MOTIVATIONS FOR VACCINE ACCEPTANCE IN SOUTH AFRICA 
It is important to understand the motivations for COVID-19 vaccine acceptance, because 
tapping into those can help increase the likelihood of vaccine uptake. In the South African 
UJ-HSRC research, protecting family members and oneself is a strong motivator for 
taking the vaccine. For instance, among the likely acceptors , 29% say they would be 
vaccinated for their own protection and 25% for the protection of others. Qualitative data 
(primarily from black African participants) seem to confirm this, as in the following 
statement: ‘I would definitely get the vaccine as soon as it is available to protect my 
family and colleagues. It will also assist in getting more people back to work’.16 
VACCINE ACCESSIBILITY IN SOUTH AFRICA 
Vaccine confidence and acceptance can be influenced by a lack of access to the vaccine 
or inadequate vaccination services. Access to the COVID-19 vaccine can be a tense 
subject, especially in low and- middle- income countries (LMICs), which struggle on 
getting sufficient supply of the vaccine on one hand, and ensuring equitable distribution 
and access across the country, on the other. Both aspects contribute to attitudes towards 
the new vaccine and the vaccination campaign.23 Conversations tracked on social media 
in South Africa in February also reflected concern about accessibility, including which 
vaccine would be available and how individuals could register for vaccination.24 
VACCINE NATIONALISM 
Vaccine nationalism refers to prioritising the interests of a single country when it comes 
to acquiring and administering vaccines25. The term has come into popular use during 
the COVID-19 pandemic as wealthy countries have purchased more doses than they need 
whilst under-resourced countries are left to scramble for sufficient supplies for their 
citizens. Vaccine nationalism threatens the international community’s goal of improving 
global health outcomes and achieving global economic recovery. It can also have a real 
effect on a population’s acceptance of vaccination. 
Vaccine shortages in South Africa, and the overall unequal distribution of supplies among 
rich and poor countries may be a reminder of the crisis in access to HIV treatment from 
the late 1990s. Antiretroviral drugs were widely available in the west but they were too 
expensive for most countries in Africa.26 As word of current vaccine shortages spreads, 
South Africans are saying, in effect, “here we go again, the global North holding all the 
vaccines.”(KII 2) Some people on social media have expressed particular frustration with 
shortages given that South Africa hosted multiple clinical trials of COVID-19 vaccine.27 
“Those kind of global inequalities are going around in the public.”(KII 2)  
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South Africa’s history of racial and class divisions, inequality, and colonialism create an 
atmosphere in which scepticism about equitable vaccine access can flourish. The country 
remains one of the most unequal in the world, according to the World Bank.28 The 
healthcare system reflects this. There are accented inequalities between urban and rural 
areas and between private health care and the under-resourced public health system 
that covers 84% of the population, mainly the poor and black working class.29,30 
Citizens have mobilised to pressure the government for timely availability of vaccines at 
the national scale, both through protests and initiatives such as the People’s Vaccine 
Campaign.31 Online conversations tracked by media analysis also focused on the 
availability of COVID-19 vaccines in the region. Major concerns have been around whether 
governments and the COVID-19 Vaccines Global Access (COVAX) initiative are doing 
enough to guarantee equitable and widespread access to vaccines through transparent 
acquisition and distribution mechanisms.32 
Some evidence suggests that affordability of an approved COVID-19 vaccine is also a 
serious concern among South Africans. A GeoPoll survey conducted in November 2020 
found that nearly a third of South Africans surveyed think a vaccine will go to those who 
can pay.23 Although, in the UJ-HSRC study, 4% of the sampled vaccine hesitant responses 
expressed concerns about affordability. The government announced in January 2021 that 
the vaccine would be administered at no charge to all uninsured South Africans,33 it is 
likely that concerns will remain among certain population groups.  
PRIORITY GROUPS  
Healthcare workers (HCW) at the frontline of the pandemic in South Africa are prioritised 
to the first phase of the rollout.  As influential communicators, ensuring their support is 
critical for vaccine uptake in the following phases.  The rapid assessment survey of HCW 
(n=22,751), found that 19% were unsure they would take the vaccine and 74% would be 
willing to recommend the vaccination to their patients.21 Note that data were collected 
prior to the launch of the AZ vaccine, which was subsequently halted, and did not include 
insights about the change to J&J vaccine. 
Phase two of the roll out will be for the elderly, people with comorbidities and essential 
workers. It will also include people living in confined settings, such as care homes and 
prisons where close contact increases risk. Phase two groups are more difficult to reach 
than HCW, and outreach strategies, such as setting up vaccination sites at clinics, social 
grant delivery points, care homes and churches, will be required. (KII 1) Outreach teams 
of community health workers can be valuable for this type of intervention. However, it 
should be recognised that eligibility rules may cause conflict with non-priority groups. For 
instance, social media users displayed anger about a proposal to include prisoners among 
the priority groups in the vaccine rollout.32 Communication materials should therefore 
explain the prioritisation criteria for certain populations. 
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MIGRANT AND REFUGEE POPULATIONS 
Vulnerable population groups may face unique challenges to vaccine accessibility. 
Ensuring the scale up of vaccination for hard-to-reach communities, such as refugees, 
migrants, and other undocumented residents (collectively referred to here as “migrants”) 
is critical to halting the pandemic by reducing the number of cases that require 
hospitalization and reduce the number of deaths and herd immunity.34 While reliable 
figures on undocumented immigrants to South Africa are hard to access, government 
figures suggest there are 1.6 million residents who were born outside of the country.35 
There is also a high rate of internal migration (e.g. labour migrants).36 
There is currently little information available on any vaccination plans for the migrant 
population. These individuals, who may already be invisible to the authorities, are at risk 
of being overlooked by vaccination campaigns. Experts have expressed concerns that 
there will be “either formal or ‘de facto’ discrimination against undocumented migrants 
when it comes to vaccine access”.35 They have also expressed concern that the growing 
emphasis on militarised responses to COVID-19 in South Africa risks undermining efforts 
to develop 'migration-aware and mobility-competent' response strategies and 
generating even more hostile environments for these populations. In addition, there is a 
risk that focus on ensuring migrant access to vaccines will be seen as improperly 
prioritising them. (KII 3) As a result it is important that statements about specific plans to 
reach migrants make clear that ensuring their inclusion will benefit the South African 
public at large. 
There are concerns about the demand side of vaccination as well. Research about 
perceptions of migrant groups is scarce, but experiences from other vaccination 
campaigns demonstrate that a lack of trust in the institutions is a key barrier. Migrants 
in South Africa have a history of unpleasant encounters with the healthcare system.37 
Fear, stigma and mistrust may make them unlikely to seek formal health care or come 
forward for vaccination even if it is made available to them. Some may be afraid of 
repercussions, such as deportation, if they are identified as undocumented. (KII 3)  
CONSTRAINTS TO VACCINE CONFIDENCE AND 
ACCEPTANCE  
Although a majority of South Africans surveyed across different studies would accept a 
COVID-19 vaccine if available, there is still a significant minority who remain hesitant; 35-
40% are not fully convinced or have some doubts about taking the vaccine.16 The reasons 
for this hesitancy need to be understood and addressed.  
Considerable attention has been given to conspiracy theories and other mis- and dis- 
information as drivers of vaccine hesitancy. However, in the South African studies other 
factors have been identified as equally or more influential. These include concerns about 
side effects, complacency regarding the individual risk of getting infected with COVID-19, 
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distrust in the vaccines in general and in the government, disbelief in the existence of 
COVID-19, lack of knowledge, and lack of time or money to travel to vaccination sites.16,18,19 
SAFETY AND EFFECTIVENESS 
In several studies, the main reasons South Africans point out for not willing to take the 
vaccine are concerns related to its safety and effectiveness.. A GeoPoll study found that 
the percentage of respondents who strongly or somewhat agree that vaccines are safe 
and effective is 56% and 60%, respectively.23 Among respondents in an IPSOS poll who 
would not take the vaccine if available, the most frequently cited reasons for hesitancy 
are concern about the side effects (39%) and concern that a vaccine is moving too quickly 
through clinical trials (33%).18 In the UJ-HSRC survey the most common explanations for 
vaccine non-acceptance are concerns about side effects, concerns about effectiveness 
and distrust of the vaccines (25%, 18% and 14% respectively).16 Other research and media 
monitoring reveals concern about the use of new DNA/mRNA platforms, the lack of long-
term safety records, the effectiveness of the vaccine against the new variants of the virus, 
and the duration of the actual protection that a vaccine can offer.(KII 1)24 Community 
feedback data have demonstrated concerns about the safety of the AZ vaccine, especially 
after some European countries paused use of the vaccine.15,38 Africa CDC data indicate 
that men are more sceptical about the vaccine’s safety (66% of men and 74% of women 
think the COVID 19-vaccine is safe). For instance, targeting men with vaccine-safety 
information could be a possible beneficial intervention.15 
Some health workers in South Africa have also questioned the safety and efficacy of the 
COVID-19 vaccine. For instance, the Indaba nurses’ union has advised its 17,000 members 
to boycott the vaccine because they do not trust its safety.39 Among the HCW study 
undertaken by the Department of Health and partners, 57.5% of the reasons for concern 
were also related to safety and effectiveness of the vaccine, while only 2% were related to 
mis- and dis-information.21 
The perceived safety of vaccines in general also seems to influence perceptions of the 
COVID-19 vaccine. Of the people who think vaccines in general are safe, 84% are willing 
to take the COVID-19 vaccine, whereas half (51%) of those who think vaccines are unsafe 
would take the COVID-19 vaccine.15 South Africans do not appear to be concerned about 
the COVID-19 vaccine specifically; 24% of respondents think that vaccines in general are 
unsafe, while 26% say the same about the COVID-19 vaccine. This suggests that COVID-19 
vaccine outreach as part of a comprehensive multi-pronged response may provide an 
opportunity to address both the safety of COVID-19 vaccination and the safety of 
vaccination in general and to emphasise the positive effects and benefits of other 
immunisation efforts  
THE IMPACT OF PERCEPTIONS OF RISK  
Individual decisions about whether to get vaccinated will be equally influenced by the 
perceived risk of the vaccination (e.g., side effects) and perceived threat of the disease. If 
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people are not aware that they or their community are at a potential risk of COVID-19, 
they may be less motivated to be vaccinated.40 For instance, in the Africa CDC survey, 
those who do not think that the threat of COVID-19 has been exaggerated report a higher 
willingness to be vaccinated than those who think the threat is exaggerated (82% vs 
70%).15  
Respondents in the PERC study report they are aware of the risk COVID-19 poses to their 
country (86%), however the risk for themselves was less strongly perceived (49%), and 61% 
stated that their health would be seriously affected if infected by COVID-19.19 It should be 
noted that this survey was conducted in February, just after a second wave, and a hard 
lockdown, making perceptions of risk and threat of the virus more evident among the 
South African population. In the JHU survey, lower perceptions of threat are found among 
women, people aged 30 or younger, and rural populations. Those same groups report 
lower vaccine acceptance than their counterparts.17  
Risk perception can be influenced by a number of factors. In the UJ-HSRC study, some 
believed that strict adherence to public health protocols, such as physical distancing or 
mask wearing, was sufficient protection from the virus. Others believed that their 
immune system would protect them without need for a vaccine.16 Comments on social 
media reflect similar scepticism about whether a vaccine is needed to supplement an 
individual’s immune response: “A vaccine stimulates my immune system to develop anti 
bodies against covid. My immune system does exactly the same on its own. Why would 
I need a vaccine?” (Twitter).41 Belief in the effectiveness of existing and potential 
treatments, including traditional healings and herbal remedies, also influences vaccine 
hesitancy. Social media references to herbal remedies as alternative treatments to 
“western medicine” surged in early February following the suspension of the AZ 
vaccination campaign.19,42 PERC data also suggest that belief in herbal remedies to fight 
the virus is high (62%) in South Africa. In the Africa CDC survey, 18% of the respondents 
express confidence that there will be other effective treatments soon, which was a main 
reason for vaccine hesitancy.15  
MISINFORMATION, RUMOURS AND CONSPIRACY THEORIES 
Even before COVID-19, conspiracy theories about vaccines were widespread across Africa. 
Long-circulating rumours in Nigeria say vaccines make people infertile or contain 
surveillance chips. Ebola vaccine trials in Ghana were suspended in 2015 due to 
allegations that scientists were planning to infect people with the disease.43 Conspiracy 
theories and other rumours about the genesis and existence of COVID-19 have also 
circulated since the beginning of the pandemic and are likely to affect acceptance of the 
vaccine as well. In the East and Southern Africa region, South Africa accounts for the 
highest number of social media engagements generated by rumours and concerns.24 
Rumours and misinformation, or the so called infodemic.44 has been identified as one of 
the major threats to vaccine acceptance.45 However, some experts have warned about 
putting excessive focus on conspiracy theories as a main factor driving vaccine hesitancy, 
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as it can undermine efforts to address other “legitimate concerns and doubts”. (KII 1; KII 
2) In addition, South African data indicate that conspiracy theories are far less influential 
than other factors, such as fear of side effects, distrust in government and institutions, etc. 
For example, in the UJ-HSRC survey, conspiracy theories account for only a small (7%) 
share of the reasons for vaccine refusal. Among the conspiracies expressed by 
respondents are those related to links between 5G technology and COVID-19,15,16 
particularly after a local councillor, Chief Justice Mogoeng, made statements in the media 
about it.41 Others said they believe the vaccine came from or is associated with the devil,16 
while others link the vaccine with a conspiracy to kill sections of the population16 – a 
charge that has frequently been made about the virus itself. Bill Gates has become a 
target for anti-vaccination conspiracy theories on social media, where users have also 
blamed him for the B.1.351 variant and have claimed that he planned the pandemic to 
“destroy Africa”.19,41 
Rumours and misinformation are often rooted in a history of colonialism, oppression and 
exploitation in South Africa. They can easily escalate, especially within the current  context 
of global vaccine inequality. Past experiences can lead to the development of conspiracy 
theories. It is thus essential to understand the context in which the South Africa 
vaccination campaign takes place. This includes influences of other African countries’ 
legacies which have on occasion have experienced unethical medical practices. For 
example the controversial meningitis drug trial in Nigeria in the 1990s when eleven 
children died, and others were paralyzed. In South Africa, many recall HIV vaccine trials in 
the mid-2000s that wrapped up hastily after authorities discovered that not only was the 
drug powerless against infection, but that it potentially made those who took it even 
more vulnerable.46 Likewise, the polio boycott in Northern Nigeria in 2003, where political 
and religious leaders argued that the vaccine could be contaminated with anti-fertility 
agents, HIV, and cancerous agents.47 It is important to include and recognise historical 
events and mistakes when introducing new vaccines.  
TRUST IN THE GOVERNMENT AND INSTITUTIONS 
Scepticism that the lives of people in South Africa really matter to foreign vaccine 
developers and the government are also rooted in the country’s history. Vaccine 
confidence and trust in the response is informed by trust in government and other 
entities more generally, and also in the historical and contemporary relationships 
between citizens and the state. Responses that raise concerns about the ability to trust 
institutional powers, such as the government, 'the system', or the WHO, are also reasons 
for vaccine hesitancy.  
Narratives in traditional and social media about the COVID-19 pandemic reflect high 
levels of distrust in government and allegations of corruption. Sixty eight percent of 
respondents were satisfied with the South African government’s response to the 
pandemic, which was amongst the lowest in the African Union southern region. The 
degree of satisfaction with the government’s response varies by education level: 43% of 
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those without a secondary school degree report being “very satisfied”, compared to 29% 
of those with a university degree.19 Between August 2020 and January 2021, criticism of 
the government’s response was often connected to broader accusations of corruption 
against the president and ruling African National Congress (ANC). An auditor general’s 
report cited “significant faults” in the management processes related to government’s 
COVID-19 spendings.48 Social media users frequently aired frustration at instances of 
noncompliance with public health measures (e.g., mask wearing and physical distancing) 
among elected officials.19 
The UJ-HSRC study also reveals that people’s trust and satisfaction with political 
leadership can be strongly associated with their views on vaccination. For instance, 
people who thought the president is doing a good job are more likely to want vaccination 
(73%), compared to those who thought the president is doing a poor job (36%). Notably, 
vaccine acceptance decreased to 48% amongst those who said they would not vote.16 
Vaccine hesitancy research has demonstrated failure by the governments to respond 
to important citizens’ needs related to security, water, sanitation, and food security, 
which may breed mistrust in other areas, including vaccination.49 In these contexts, 
communities are more likely to perceive any government-provided interventions with 
suspicion.  
In South Africa, comments reflecting distrust in western vaccines and worries about 
Africans being used to test vaccines were widely shared on social media at the time of the 
rollout of the J&J vaccine, which started without a formal licence in South Africa.50 
Suspicion about the vaccine was reflected in community feedback and social listening 
data, such as: “The vaccine will be used to control people using a registry”.41 Reports of 
planned mandatory vaccinations (e.g. HCWs and children) may amplify mistrust in the 
government and institutions and generated angry responses on social media.51 Although 
the government has denied such plans, fears and rumours remain.52  
LACK OF KNOWLEDGE 
Many of the above concerns are grounded in a lack of knowledge and information about 
the vaccine, the trials and the vaccine rollout programme. Data released by PERC showed 
that of the 39% of respondents who said they would refuse to take the vaccine, one in four 
stated the main reason was not having enough information to make a decision.19 Among 
the HCW survey conducted in February by the Department of Health and partners,21  
individual concerns were highlighted by the respondents, for instance how to manage 
pre-existing conditions, effects on breastfeeding and pregnancy and also where and how 
to get personal health advice. Targeted information and accessible knowledge points 
ensuring two way communication for HCW is essential to support efforts of explain to 
people how vaccines work and how they are trialled.  
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ADDRESSING VACCINE HESITANCY AND INCREASING  
UPTAKE IN SOUTH AFRICA 
As noted, a majority of South Africans surveyed across the different studies would get a 
COVID-19 vaccine if it was available. However, 35-40% are not fully convinced or have some 
doubts.16 This should be the target population for communication and engagement 
efforts– what experts have called ‘the movable middle,’ who can be swayed from 
hesitancy to acceptance. (KII 1) Reasonable concerns may be addressed by positive 
messaging that builds on local terminologies and understandings of health, 
immunity and social health and engages with people’s values, beliefs, and trust. For 
instance, the Zulu term ubuntu means ‘I am because you are’. So, ‘vaccine ubuntu’ frames 
the message in local terms as ‘I am safe because you are safe and you are safe because I 
am safe’. Shifting the narrative is an important element when  designing more 
comprehensive interventions, this can help to ground the interventions in local 
communities’ social and cultural practices and realities. It thus may not only inform, but 
also shape new sociocultural norms and social practices.53 
TRUSTED INFORMATION SOURCES AND INFLUENCERS 
People's perceptions of vaccines and vaccination programmes can be influenced and 
shaped by trusted local actors.13 In South Africa, civil organisations are popular, and for 
many people they are a trusted source of information and advice. This was confirmed by 
Africa CDC data.15 Religious leaders, traditional healers and local health providers also 
have an important role to play, for example publicly vaccinating ministers, imams, rabbis 
and incorporating the discussions about vaccines into services and ceremonies may 
encourage acceptance and credulity in national vaccination efforts.54 Churches – the 
most influential organisations in the country –  also have a useful role, especially in 
reaching rural areas.55 The Zion Christian Church for example, with estimated 9 million 
members in the country, could be an important partner to promote vaccine acceptance.56 
Collaboration with these parties could have benefits in terms of trust towards the vaccine 
and in reaching some populations that are often excluded. Social media campaigns 
sharing accurate information and building literacy can also play an important role, 
especially reaching younger populations. Schools and universities may have the ability to 
play an important role in reaching adolescent and young adult populations, who are 
amongst the most hesitant groups. 
The JHU KAP survey indicates that the most trusted sources of information noted by 
South Africans are scientists, doctors, and health experts (74%), followed by the WHO 
(65%) and local health workers, clinics and community organisations (59%). TV, 
newspapers, and radio are in the middle rankings around 53%; similarly, ordinary people 
known personally are similarly trusted as online sources and messaging apps, SMS, and 
texts messaging (27%, 28%, 29% respectively). Politicians were trusted by the fewest 
participants (15%).17 Targeted communication strategies can and should be developed 
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and shared in collaboration with trusted organisations and individuals. More research is 
necessary to identify groups, and target and reach those individuals properly. 
APPROACHES TO ADDRESS HESITANCY 
It is essential that RCCE strategies and vaccination delivery strategies be tailored to 
individual groups. For example, methods to reach migrants for vaccination need to 
recognise that they may not have a fixed place of residence and may have specific 
concerns about engaging with the health system. Lessons on how to engage and reach 
these communities can be taken from previous experiences with the HIV vaccination 
campaign, where marginalised groups were the priority target population. Safe spaces 
with social and environmental conditions conducive to trust were established, so that 
these populations could feel comfortable.  
PARTICIPATORY APPROACHES IN THE WESTERN CAPE 
Approaches should also be developed with the guidance of affected groups. For example, 
following an initial survey suggesting high levels of vaccine hesitancy, emergency 
medical services (EMS) colleagues in a Western Cape Vaccination Centre used 
participatory methods to develop a series of initiatives to address this.  Initially, a series of 
focus groups were held with staff (including medics, paramedics, security members, 
cleaners, etc.) to identify themes related to vaccine acceptance. A rapid analysis of these 
data was then triangulated with qualitative evidence which was used to design a series 
of interventions. Recognising that addressing concerns was not just about providing the 
facts, but required a deeper engagement with these concerns, and that it’s not just ‘what 
you say’ but ‘how you say it’ and ‘who says it’ a group of trusted staff members would need 
to be equipped with the necessary skills and knowledge. Social networks shape 
vaccination perceptions57 and thus staff from multiple parts of the department were 
selected to be part of the interventions. Finally, the qualitative work led to wider 
acceptance amongst the rollout team that the technical parts of the rollout were 
important, but needed a strong focus on equity of access and should be accompanied by 
a trust building limb. (KII 4) 
The set of interventions were as follows:  First, a group of staff from different parts of the 
department were received training to equip them to be trusted sources of vaccine 
knowledge. Next, a call centre was set up to call all staff members to discuss their 
concerns and provide answers to questions (where possible, this was done in a language 
of their choice and calls were done in English, Afrikaans and Xhosa). Next, a series of 
videos58–60 were created and widely shared among the participants and between their 
networks. These were not educational videos, but instead were focused on building trust 
in the process, and sharing experience of staff receiving the vaccine to reduce fear. EMS 
staffed who received their vaccines first were also encouraged to share on social media 
to build wider vaccine acceptance. Lastly, an operational team that continued to use the 
call centre was selected.  This team worked solidly on the roll-out logistics ensuring high-
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risk staff were prioritised (giving equal preference to urban and rural based staff), 
supporting colleagues with technical problems (largely with the online registration 
required) and arranging transport to vaccination sites to reduce vaccine access issues. By 
early April 2021, 75% of EMS staff had received their vaccines and the major became the 
availability of vaccines. (KII 4) This localised initiative can serve as an example for how to 
engage with HCW and emergency personnel using a bottom-up initiative. HCW are an 
important group to target, as they are promoters of vaccine acceptance and are trusted 
information sources in their communities. Building Community Resilience  
CIVIL SOCIETY AND COMMUNITY-LED APPROACHES 
Attempts to address vaccine hesitancy should consider community resilience, 
recognising that communities may have acquired knowledge and developed response 
strategies during prior experiences with infectious disease outbreaks. Local capacities can 
be adapted and used during a crisis to cope, mitigate harm, and recover, while 
simultaneously building community. Such an approach encourages working together 
with affected groups to mitigate the impact of the pandemic; in this case it can be applied 
to promote vaccine acceptance and information.61–63 When evaluating initiatives such as 
a COVID-19 vaccination programme, it is important to assess existing community-led 
measures and develop interventions in collaboration with the community that endorse 
and complement those existing measures and support co-production of knowledge. 
Civil organisations in South Africa gained experience in health interventions during the 
HIV outbreaks. For instance, platforms to discuss health policy change emerged, such as 
the Treatment Action Campaign (TAC). which aimed to advocate for improved HIV/AIDS 
health service delivery.64 More recently, over 170 Community Action Networks (CANs), 
similar to TACs, have emerged in the context of the pandemic. The underlying premise of 
CANs is that many of the challenges arising from COVID-19 – both epidemiological and 
social – are best addressed at the neighbourhood level. Neighbours connect, usually 
through a WhatsApp group, and assess the immediate needs of their specific 
community; they also identify those who are more vulnerable and those who can 
volunteer to help.65 Those self-organising networks, without a hierarchy, are currently 
generating local- and community-level social data and intelligence to respond to the 
pandemic. The CANs are one example of an opportunity for government to work with 
and strengthen networks in order to provide vaccine information and support 
throughout rollout to the communities at the given moment. However, it is important for 
the government to recognise the informal nature of community networks to be able to 
work together. (KII 4) 
Government collaboration with community groups can also promote a sense of solidarity 
and unity across the population. This, in turn, can rebuild trust and tap into one of the 
main reasons given for vaccine acceptance – to protect others. In moving towards a more 
coherent and trust-based interface between such initiatives and the formal health 
system, it is imperative that engagement be bi-directional and sustained over time, 
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rather than one-off meetings and check-box style public participation, supporting long 
term engagement of action and research. (KII 4) The state must also recognise the work 
of informal networks and be willing to resource and support this work without making it 
dependent on formalisation and bureaucratisation.66 
SUMMARY TABLE OF MAIN SOURCES 
 
LINKS TO FURTHER RESOURCES 
◼ Videos by the emergency medical services (EMS) colleagues in a Western Cape 
Vaccination Centre to address vaccine hesitancy : 
• From ICU to the Vaccination Room with Sindi Dayile:  
• Still deciding if you want to take the vaccine? Check out this video on the EMS 
vaccine rollout here!: 
• Message from EMS Director on EMS rollout 
 
◼ Community Action Networks: 'Cape Town Together:  Organising in a city of islands'.  
◼ C-19 People's coalition, Towards a people's vaccine campaign: A call for action.  
◼ WHO. Data for action: achieving high uptake of COVID-19 vaccines. Interim guidance. 
◼ SSHAP. Community Resilience: Key Concepts and their Applications to Epidemic 
Shocks Brighton: Social Science in Humanitarian Action.  
◼ Collective Service for Risk Communication and Community Engagement.   
 
Organisation Study method Population 
(n) 
Timeframe of data 
collection 
Africa CDC Face to face survey 1,056 September – October 2020 
Collective service ESAR Community feedback  - November – February 2021 
Department of 
Health 
RSA & UNICEF 




Online survey 4,900,000 April 2021 
GeoPoll  Telephone surveys  500 November 2020 
IPSOS global report Online survey 500+ January 2021 
Johns Hopkins 
University (JHU) 
KAP- online survey (2 times) Jul 4,094;  
Nov 3,916 
July & November 2020 
PERC Telephone survey 1,639 February 2021 
UJ-HSRC Online survey  10,618 January 2021 
UNICEF ESARO C4D Digital and social media 
monitoring on immunization  
- November – February 2020 
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